e-learning
resources
ERS Research Seminars
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Proteases as tools for diagnosis and novel therapeutics
S. Meiners (München, Germany)
Source:
ERS Research Seminar 2015
Number:
5
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Meiners (München, Germany). Proteases as tools for diagnosis and novel therapeutics. ERS Research Seminar 2015
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Novel targets and emerging therapies in MPM
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019
Novel therapeutics for CF
Source: International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission
Year: 2019
From anti-PD1/L1 inhibitors to new immunotherapies
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019
Clinical implications and novel therapies
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018
Novel NTM treatments and approaches, repurposed to bacteriophages
Source: Virtual Congress 2021 – New insights into nontuberculous mycobacteria disease: from diagnosis to treatment
Year: 2021
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
Source: ERJ Open Res, 6 (4) 00405-2020; 10.1183/23120541.00405-2020
Year: 2020
Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008
COPD mechanisms: novel aspects and implications for new therapies
Source: ERS Live 2007
Year: 2007
COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness
Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020
Year: 2020
Classic and Novel Adipokines as diagnostic biomarkers in NSCLC
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Genomics-based identification of targets in pathogenic bacteria for potential therapeutic use
Source: Annual Congress 2004 - Novel approaches to the treatment of pneumonia
Year: 2004
Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Genetic studies as a tool for identifying novel potential targets for treatment of COPD
Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017
Year: 2017
Targeting the arginase pathway: potential developments as new avenues for treatment
Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma?
Year: 2004
The genetics of asthma and the promise of genomics-guided drug discovery
Source: Virtual Congress 2020 – Reducing the burden of asthma
Year: 2020
COPD – will new insights into molecular pathology define new therapies?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Potential of regulatory T-cell-based therapies in the management of severe COVID-19
Source: Eur Respir J, 56 (3) 2002182; 10.1183/13993003.02182-2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept